The beta-adrenergic receptors (b-AR) are G protein-coupled receptors activated by epinephrine and norepinephrine and are involved in a variety of their physiological functions. Previously, three b-AR genes (ADRB1, ADRB2 and ADRB3) were resequenced, identifying polymorphisms that were used in genetic association studies of cardiovascular and metabolic disorders. These studies have produced intriguing but inconsistent results, potentially because the known functional variants: ADRB1 Arg389Gly and Gly49Ser, ADRB2 Arg16Gly and Gln27Glu, and ADRB3 Arg64Trp provided an incomplete picture of the total functional diversity at these genes. Therefore, we created marker panels for each b-AR gene that included the known functional markers and also other markers evenly spaced and with sufficient density to identify haplotype block structure and to maximize haplotype diversity. A total of 27 markers were genotyped in 96 US Caucasians and 96 African Americans. In both populations and for each gene, a single block with little evidence of historical recombination was observed. For each gene, haplotype captured most of the information content of each functional locus, even if that locus was not genotyped, and presumably haplotype would capture the signal from unknown functional loci whose alleles are of moderate abundance. This study demonstrates the utility of using b-AR gene haplotype maps and marker panels as tools for linkage studies on b-AR function.
Introduction
The human beta-adrenergic receptors (b-AR) are G s -protein-coupled receptors that bind catecholamine neurotransmitters and signal transduce by raising intracellular levels of cyclic AMP.
1 b-AR are implicated in a variety of catecholamine-mediated physiological functions and in the pathophysiology of obesity, 2 asthma 3 and cardiovascular disorders. 4 b-AR have been classified into b1, b2 and b3 subgroups. b1 receptors are expressed in the heart, kidney, blood vessels and regulate heart rate and vascular tone. b2 receptors are widely distributed in the respiratory tract, and relax smooth muscle in small airways. b3 receptors are found mainly in adipose tissue, where they stimulate lipolysis and thermogenesis. 5 Genes encoding the three b-AR subtypes (ADRB1, hCG39839; ADRB2, hCG36934 and ADRB3, hCG21141) are located on chromosomes 10, 5 and 8, respectively. ADRB1 and ADRB2 are nonintronic, and are 3.2 and 3.4 kb, respectively. ADRB3 has one intron and is 3.7 kb in length. Functional loci have been identified at each of the b-AR genes. Two abundant ADRB1 missense variants Ser49Gly and Gly389Arg 6 alter in vitro receptor coupling 7 but have no clear in vivo significance. Some positive results were reported using these markers in linkage studies of cardiomyopathy, 8 heart and renal failure, 7, 9 and hypertension. 10 However, no relationship was detected to the response of healthy subjects to drugs acting through the b1-AR 11 nor in the hemodynamic response of hypertensive subjects to chronic b1-AR blockade. 12 Two obesity studies with the Gly389Arg marker yielded conflicting results. 13, 14 Within the coding region of ADRB2, nine SNPs were identified, 15 five of which are synonymous. Missense substitutions were Arg16Gly, Gln27Glu, Val34Met, and Thr164Ile. 16, 17 Among them, two common alleles have been shown to be functional in vitro: Gly16 leads to enhanced agonist-mediated downregulation, and Glu27 reduces such regulation. 18 31 However, the linkage studies are contradictory. 32 Taken together, this evidence illustrates that a consistent picture of b-AR genotype -phenotype relationships has yet to emerge. Other functional loci may be present, including polymorphisms which are known but which have not yet been recognized to be functional. A haplotype approach combining known functional polymorphisms with a series of loci chosen for haplotype informativeness could comprehensively capture the potential information content on b-AR functional variants of moderate abundance. 33 In this study, we report a haplotype map for each of the b-AR genes for two populations, American Caucasians and African Americans, by genotyping a panel of SNP markers and the known functional polymorphisms in these populations. For each gene, we also describe marker panels that maximize haplotype information content.
Materials and methods

Participants
A total of 192 unrelated subjects were genotyped, including 96 individuals from each of two populations: US Caucasians and African Americans. Informed consent was obtained according to human research protocols approved by the human research committees of the recruiting institutes, including the National Institute on Alcohol Abuse and Alcoholism, National Institute of Mental Health and Rutgers University. All participants had been psychiatrically interviewed and none had been diagnosed with a psychiatric disorder.
SNP markers
The physical position and frequency of minor alleles (40.05) from a commercial database (Celera Discovery System, CDS, September, 2003) were used to select SNPs (including known nonsynonymous substitutions). 5 0 nuclease assays (vide infra) were designed for seven ADRB1, 11 ADRB2 and nine ADRB3 SNPs and optimized. These markers were nearly equally spaced and covered the entire genes plus 2.5 -6 kb upstream and 2.5 -6 kb downstream from each gene.
Genomic DNA Genomic DNA was extracted from lymphoblastoid cell lines, diluted to a concentration of 10 ng/ml. Aliquots of 1 ml were dried in 384-well plates.
Polymerase chain reaction (PCR) amplification
Genotyping was performed by the 5 0 nuclease method 34 using fluorogenic allele-specific probes. Oligonucleotide primer and probe sets were designed based on gene sequence from the CDS, September 2003. Primers and detection probes for each locus in each gene are listed in Table 1a -c. Reactions were in a 5 ml volume containing 2.375 ml TE, 2.5 ml Master Mix (ABI, Foster City, CA, USA) with AmpliTaq Gold s DNA Polymerase, dNTPs, Gold Buffer and MgCl 2 , 10 ng genomic DNA, 900 nM of each forward and reverse primer and 100 nM of each reporter and quencher probe. DNA was incubated at 501C for 2 min and at 951C for 10 min, and amplified on an ABI 9700 device for 40 cycles at 951C for 30 s and 601C for 75 s. Allele-specific signals were distinguished by measuring end point 6-FAM or VIC fluorescence intensities at 508 and 560 nm, respectively, and genotypes were generated using Sequence Detection V.1.7 (ABI).
Genotyping error rate was directly determined by regenotyping 25% of the samples, randomly chosen, for each locus. The overall error rate was o0.005. Genotype completion rate was 0.99. 
Results and discussion
Of a total of 27 markers in three b-AR genes, 23 were polymorphic both in US Caucasians and African Americans. ADRB3 marker #2 (rs4999) was monomorphic in Caucasians, and ADRB3 markers 7 -9 (rs4993, rs802162 and rs13258937) were monomorphic in both populations. Dramatic interpopulation differences in allele frequencies were observed for many of the markers. Allele frequencies of all markers and their locations in the genes are shown in Table 2a -c. For ADRB1, two functional nonsynonymous polymorphisms (Ser49Gly and Ala389Gly) are located in the exon, one marker is located in the gene 3 0 UTR region, and the rest of the markers are in the intergenic region upstream and downstream of ADRB1 (Figure 1a ). For ADRB2, two functional nonsynonymous polymorphisms (Arg16Gly and Gln27Glu) and two synonymous polymorphisms are located in the exon, one marker is located in the gene 5 0 UTR region, and the rest of the markers are in the intergenic region upstream and downstream of ADRB2 (Figure 1b) . For ADRB3, one functional nonsynonymous polymorphism (Arg64Trp) is located in exon 1, one marker is located in the 5 0 UTR region (exon 1), two markers are located in the gene 3 0 UTR region (exon 2), and the rest of the markers are in the intronic sequence and intergenic region upstream and downstream of ADRB3 (Figure 1c) .
Within the ADRB1, ADRB2 and ADRB3 regions, a single conserved haplotype block spanned each gene in both Caucasians and African Americans (Figure 2a -c) values within the haplotypes blocks from both Caucasians and African Americans were high: ADRB1: 1.00 and 1.00, ADRB2: 1.00 and 1.00, and ADRB3: 1.00 and 0.93, indicating that most pairs of loci within these regions are in very high LD.
Haplotype frequencies for ADRB1, ADRB2 and ADRB3 in both populations are shown in Table 3a -c. For each population and haplotype block, 2 -5 common (frequency X0.05) haplotypes accounted for most of the total: 88 -100% of Caucasian and 88 -96% of African-American haplotypes. For US Caucasians and African Americans, the numbers of common (frequency X0.05) haplotypes were: in ADRB1, 3 and 5; in ADRB2, 4; in ADRB3, 2 and 4, respectively. Population differences in haplotype frequencies are clearly illustrated in Figure 3a -c.
The marker panels we genotyped were sufficient to capture diversity in all blocks in the two populations we studied. We evaluated haplotype diversity within each block by successively subtracting SNPs from the haplotypes Marker #6 is known functional polymorphism; marker #2 is monomorphic in Caucasians, and ##7 -9 are monomorphic in both Caucasians and African Americans and then excluded from LD matrix (Figure 2c) .
to evaluate the increment/decrement in diversity contributed by each SNP. SNPs were serially subtracted in that order that minimized the decrement in diversity at each step, and until only a single SNP (ie the SNP with the highest heterozygosity) remained. The chosen measure of diversity (haplotype frequencies and diplotype heterozygosity) was recalculated for each size SNP panel [n, nÀ1,y,1]. At some point for each haplotype block and for each population, adding or subtracting a SNP does not appreciably alter diversity, as shown in Figure 4 , panels A-C. For ADRB1and ADRB2, haplotype diversity was highest in African Americans. A similar number of markers (2 -4) was sufficient to capture maximum diversity in either population. This number represents an optimal panel, itself derived from the larger panel of SNP markers we genotyped. The minimum SNP set necessary to maximize haplotype diversity was also determined using SNPTagger. 37 The SNPs that constitute this minimal set are indicated in Table 2a Table 4a -c). Haplotypes enabled high sensitivity of detection of the missense substitutions (when a missense allele was present a particular haplotype(s) was present) and specificity of detection (when a haplotype(s) was present the missense allele was present). For each of the three b-AR genes, the haplotype was capable of capturing all or almost all the information provided by directly genotyping the missense loci, in either population (Table 5a, 0 between locus pairs. *ADRB3 marker #2, monomorphic in Caucasians, is excluded from the Caucasian haplotype map, but included, for comparability to African Americans, in all haplotypes (see Table 3c ). polymorphisms that affect gene expression and/or function is highly important in association/linkage studies. However, there is a possibility that an unrecognized functional locus contributes to a phenotype. The focus of the haplotype-based approach to analyzing case -control populations has been to detect the effects of every functional locus, known or unknown. For the b-AR genes, we have created multilocus SNP panels to define haplotype structure across each gene region. Each panel is sufficient to capture the signal of the moderately abundant missense alleles and unknown functional loci. The b-AR gene haplotype maps and marker panels provide a basis for future studies to investigate the role of genetic variation in physiology and pathophysiology related to b-AR function. 
